Literature DB >> 1438211

CD22-mediated stimulation of T cells regulates T-cell receptor/CD3-induced signaling.

A Aruffo1, S B Kanner, D Sgroi, J A Ledbetter, I Stamenkovic.   

Abstract

Interaction between B lymphocytes and other cell types is mediated in part by the B-cell adhesion molecule CD22. Recent work has suggested one of the T-cell ligands of B cells to be CD45RO, an isoform of the receptor-linked phosphotyrosine phosphatase CD45. Here we demonstrate direct interaction between CD22 and several isoforms of CD45, including CD45RO, and propose that the interaction may participate in regulation of lymphocyte signaling. Cross-linking of CD3 and CD22 T-cell ligands with anti-CD3 antibody and soluble CD22 is shown to block anti-CD3-induced intracellular calcium increase and to inhibit tyrosine phosphorylation of phospholipase C gamma 1. These effects are consistent with those observed upon coligation of CD3 and CD45 with antibody, providing support to the possibility that ligand-mediated stimulation of CD45 may result in modulation of substrate phosphorylation and lymphocyte activation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1438211      PMCID: PMC50314          DOI: 10.1073/pnas.89.21.10242

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  46 in total

1.  The B lymphocyte adhesion molecule CD22 interacts with leukocyte common antigen CD45RO on T cells and alpha 2-6 sialyltransferase, CD75, on B cells.

Authors:  I Stamenkovic; D Sgroi; A Aruffo; M S Sy; T Anderson
Journal:  Cell       Date:  1991-09-20       Impact factor: 41.582

Review 2.  CD45. A prototype for transmembrane protein tyrosine phosphatases.

Authors:  I S Trowbridge
Journal:  J Biol Chem       Date:  1991-12-15       Impact factor: 5.157

3.  The specific direct interaction of helper T cells and antigen-presenting B cells.

Authors:  A Kupfer; S L Swain; C A Janeway; S J Singer
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

4.  Kinetics of homophilic binding by embryonic and adult forms of the neural cell adhesion molecule.

Authors:  S Hoffman; G M Edelman
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

5.  CD62/P-selectin recognition of myeloid and tumor cell sulfatides.

Authors:  A Aruffo; W Kolanus; G Walz; P Fredman; B Seed
Journal:  Cell       Date:  1991-10-04       Impact factor: 41.582

6.  The B-cell surface protein CD72/Lyb-2 is the ligand for CD5.

Authors:  H Van de Velde; I von Hoegen; W Luo; J R Parnes; K Thielemans
Journal:  Nature       Date:  1991-06-20       Impact factor: 49.962

7.  Functional activation of the T-cell antigen receptor induces tyrosine phosphorylation of phospholipase C-gamma 1.

Authors:  A Weiss; G Koretzky; R C Schatzman; T Kadlecek
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

8.  CD3 stimulation causes phosphorylation of phospholipase C-gamma 1 on serine and tyrosine residues in a human T-cell line.

Authors:  D J Park; H W Rho; S G Rhee
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

9.  Activators of protein kinase C down-regulate and phosphorylate the T3/T-cell antigen receptor complex of human T lymphocytes.

Authors:  D A Cantrell; A A Davies; M J Crumpton
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

10.  PLC gamma 1, a possible mediator of T cell receptor function.

Authors:  C Granja; L L Lin; E J Yunis; V Relias; J D Dasgupta
Journal:  J Biol Chem       Date:  1991-09-05       Impact factor: 5.157

View more
  21 in total

1.  Epitope specificity of the anti-(B cell lymphoma) monoclonal antibody, LL2.

Authors:  R Stein; E Belisle; H J Hansen; D M Goldenberg
Journal:  Cancer Immunol Immunother       Date:  1993-10       Impact factor: 6.968

2.  In situ trans ligands of CD22 identified by glycan-protein photocross-linking-enabled proteomics.

Authors:  T N C Ramya; Eranthie Weerapana; Lujian Liao; Ying Zeng; Hiroaki Tateno; Liang Liao; John R Yates; Benjamin F Cravatt; James C Paulson
Journal:  Mol Cell Proteomics       Date:  2010-02-19       Impact factor: 5.911

Review 3.  The Sialoadhesins--a family of sialic acid-dependent cellular recognition molecules within the immunoglobulin superfamily.

Authors:  S Kelm; R Schauer; P R Crocker
Journal:  Glycoconj J       Date:  1996-12       Impact factor: 2.916

Review 4.  Viewing Siglecs through the lens of tumor immunology.

Authors:  Isabella Fraschilla; Shiv Pillai
Journal:  Immunol Rev       Date:  2017-03       Impact factor: 12.988

5.  Masking of CD22 by cis ligands does not prevent redistribution of CD22 to sites of cell contact.

Authors:  Brian E Collins; Ola Blixt; Alexis R DeSieno; Nicolai Bovin; Jamey D Marth; James C Paulson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-12       Impact factor: 11.205

6.  CD22 associates with the human surface IgM-B-cell antigen receptor complex.

Authors:  C Leprince; K E Draves; R L Geahlen; J A Ledbetter; E A Clark
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

Review 7.  CD22: an inhibitory enigma.

Authors:  Jennifer A Walker; Kenneth G C Smith
Journal:  Immunology       Date:  2007-12-07       Impact factor: 7.397

8.  Regulation of CD45 engagement by the B-cell receptor CD22.

Authors:  D Sgroi; G A Koretzky; I Stamenkovic
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

9.  Sialoadhesin binds preferentially to cells of the granulocytic lineage.

Authors:  P R Crocker; S Freeman; S Gordon; S Kelm
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

10.  Unmasking of CD22 Co-receptor on Germinal Center B-cells Occurs by Alternative Mechanisms in Mouse and Man.

Authors:  Matthew S Macauley; Norihito Kawasaki; Wenjie Peng; Shui-Hua Wang; Yuan He; Britni M Arlian; Ryan McBride; Reiji Kannagi; Kay-Hooi Khoo; James C Paulson
Journal:  J Biol Chem       Date:  2015-10-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.